PharmaClik Login 
Pharmacists are highly trained healthcare professionals who play a vital role in the management of patients' health, including the prescribing of medications. Pharmacist prescribing authority – their ability to prescribe medications, initiate and adjust doses, and manage drug therapeutic substitutions for patients without the need for physician involvement – has been an ongoing topic of policy discussions across all Canadian provinces in the aftermath of the COVID-19 pandemic. Expanding prescribing authority to pharmacists’ full capabilities across all provinces has never been more urgent and relevant than in this period of severe, enduring healthcare professional shortage across the country.
Press Releases - McKesson Canada
Press Releases
Stay Informed with Our Latest Healthcare Updates and Announcements
Press Releases
Stay Informed with Our Latest Healthcare Updates and Announcements
24/10/24
Princess Margaret Cancer Centre and McKesson Canada partner to elevate best practices for cancer treatment in community infusion clinics
Toronto, ON (October 24, 2024) – Princess Margaret Cancer Centre, part of University Health Network in Toronto, has partnered with McKesson Canada to implement best practices for the delivery of high-quality care to cancer patients who receive treatment in the organization’s network of community infusion clinics.
As part of their cancer journey, some oncology patients use independent, community-based infusion clinics, which can offer a wider variety of treatment options for patients and provide access to leading edge medicines. This partnership will benefit patients and ensure they receive the same level of seamless, high-quality care at McKesson Canada’s INVIVA clinics as they do at Princess Margaret.
To date, formal relationships between community infusion clinics and cancer centres have been limited. Before launching the partnership, Princess Margaret conducted a comprehensive inspection of McKesson Canada’s oncology services, which are accredited by Accreditation Canada, including its infusion clinics and pharmacy at its central Toronto location. With the partnership now in place, Princess Margaret and McKesson Canada look forward to working together to align quality standards.
About Princess Margaret Cancer Centre
The Princess Margaret Cancer Centre has gained an international reputation as a global leader in the fight against cancer and delivering personalized cancer medicine. The Princess Margaret, one of the top five international cancer research centres, is part of University Health Network in Toronto. For more information: www.theprincessmargaret.ca
About McKesson Canada
McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver products, services and insights to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.
For media inquiries:
The Princess Margaret Cancer Centre
Marina Jimenez
McKesson Canada
Sybil Millar
05/09/24
McKesson Corporation Announces Sale of Rexall and Well.ca Businesses to Birch Hill Equity Partners
IRVING, Texas, [September 5, 2024]—McKesson Corporation (NYSE: MCK) announced today that it has signed an agreement to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm.
In line with McKesson Corporation’s enterprise strategy, this transaction enables McKesson to further focus and prioritize investments to grow its oncology and biopharma services platforms. McKesson Corporation remains fully committed to and confident in the strength of our Canadian distribution and biopharma businesses, delivering solutions to ensure the delivery of better health outcomes.
“This transaction marks an important milestone aligned to our enterprise strategy, advancing our strategic priorities, further streamlining our business and prioritizing investment in our growth areas of oncology and biopharma services,” said Brian Tyler, Chief Executive Officer, McKesson. “We remain fully committed to and confident in the strength of our Canadian distribution and biopharma businesses. I am proud of the accomplishments that Rexall and Well.ca have achieved with McKesson and I have every confidence that both businesses will flourish under Birch Hill’s ownership.”
Birch Hill Equity Partners is a mid-market Canadian private equity firm with more than 30 years of experience supporting Canadian companies on driving growth initiatives. Through this transaction, we believe Rexall and Well.ca will have a partner committed to investing the resources and capital needed to build on the businesses’ strong foundation, while providing services to Canadians from more locations, to address critical healthcare needs. McKesson Canada continues to see value in Rexall and Well.ca and intends to remain a wholesale distribution supplier to each business.
McKesson Canada will continue to own and operate Rexall and Well.ca until transaction close, which is subject to customary closing conditions, including necessary regulatory clearances.
Cautionary Statements
Except for historical information, statements in this press release related to McKesson’s proposed disposition of the Rexall and Well.ca operations and assets in Canada constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve risks and uncertainties that could cause actual results to differ materially from those in those statements. It is not possible to identify all such risks and uncertainties. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the company undertakes no obligation to publicly update forward-looking statements. We encourage investors to read the important risk factors described in the company’s most recent Form 10-K filed with the Securities and Exchange Commission. These risk factors include, but are not limited to: we might be adversely impacted by delays or other difficulties with divestitures such as the transactions described in this press release; we from time to time record significant charges from impairment to goodwill, intangibles and other assets or investments; we might be adversely impacted by events outside of our control, such as widespread public health issues, natural disasters, political events and other catastrophic events.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable.Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.
Investor Contact
Rachel Rodriguez
469-260-0556
Rachel.Rodriguez@McKesson.com
Media Contact
Media@mckesson.ca
19/04/24
Rexall Launches First Pharmacist Care Walk-In Clinic in Barrie
Local Rexall® pharmacists can now assess and provide required care for common illnesses, addressing immediate healthcare needs and promoting preventive care.
BARRIE, ON, April 19, 2024 /CNW/ - Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for minor illnesses, as well as services including chronic disease management, vaccinations, men's and women's health, and point-of-care testing, among others.
Rexall's Pharmacist Care Walk-In Clinic is dedicated to enhancing accessible healthcare by increasing the value pharmacists provide to patients, especially when it comes to preventative healthcare and chronic condition management. We are taking a collaborative approach to work with primary care physicians throughout the Barrie community. Additionally, we offer virtual physician care services when needed, further improving access to comprehensive care for our patients.
"We are pleased to announce the opening of our Pharmacist Care Walk-In Clinic, which will enhance healthcare access in the Barrie community by empowering local pharmacists to assess and provide necessary care for immediate health concerns and improving long-term health outcomes," says Qaiser Hassan, pharmacy manager for the Barrie Rexall Pharmacist Care Walk-In Clinic. "We look forward to empowering individuals in the Barrie community to actively manage a healthy and happy lifestyle. This initiative brings us closer to strengthening the bond between healthcare providers and patients, aligning with Rexall's commitment to caring for Canadians' health, one person at a time."
Services that will be offered to patients at the Pharmacist Care Walk-In Clinic include:
• Minor illnesses (mild acne, UTI, pink eye, eczema, cold sores, seasonal allergies, etc.)
• Chronic disease management (diabetes, hypertension, etc.)
• Women's and men's health
• Travel health and vaccinations
• Point of care testing (Lipids, A1C, COVID, etc.)
• Immunization and injections
• Smoking cessation
• Prescription refills and renewals
• On-site physician virtual care
The launch event on Friday, April 19th, 2024, will feature a ribbon-cutting ceremony, guided tours of the clinic's state-of-the-art facilities, and a chance to meet the passionate healthcare professionals who will be serving the community.
For more information, please visit rexall.ca/clinic-duckworth
Rexall Barrie Pharmacy Care Walk-In Clinic Team. Photo by Stephan Potopnyk (CNW Group/Rexall Pharmacy Group ULC.)
Rexall celebrates their first Ontario pharmacy walk-in clinic opening in Barrie, Ontario. Photo by Stephan Potopnyk (CNW Group/Rexall Pharmacy Group ULC.)
About Rexall
With a dynamic history of innovation and growth dating back over a century, Rexall is a leading pharmacy retailer in Canada, dedicated to caring for Canada's health, one person at a time. Operating approximately 400 pharmacies across Canada, Rexall's 8,000 employees provide compassionate care to patients, becoming their trusted health partners along their wellness journey.
Rexall is part of the Rexall Pharmacy Group ULC and a proud member of the global McKesson Canada Corporation family, a diversified healthcare company with deep roots in supporting patients across Canada.
For more information, visit rexall.ca. Follow us on Twitter: @RexallDrugStore, on Instagram at @RexallDrugStoreOfficial, and @RexallCareNetwork and on Facebook at @RexallDrugStore
SOURCE Rexall Pharmacy Group ULC.
For further information: Media Contact, media@rexall.ca
27/02/24
McKesson Canada Named One of Montreal's Top Employers for the Seventh Consecutive Year
Montreal, QC (February 27, 2024) – For the seventh consecutive year, McKesson Canada has been recognized as one of Montreal's Top Employers for 2024. The award is in recognition of the organization’s leading practices and benefits that enable employees to take charge of their health and wellbeing, its charitable giving, and for creating a flexible work culture where employees feel welcomed, valued and included.
“At McKesson Canada, our amazing talent are innovative and driven thinkers representing a wealth of backgrounds, perspectives, and experience,” says Joan Eliasek, President, McKesson Canada.
“Together, we set the foundation for an outstanding work culture that draws on the richness of our diverse viewpoints and skillsets to help us grow, personally and professionally; foster a sense of belonging; and advance health outcomes for all.”
McKesson Canada plays a pivotal role in Canadian healthcare by providing solutions to manufacturers, pharmacies, hospitals and various healthcare institutions who serve the needs of patients every day. It brings together clinical knowledge, process expertise, technology and resources to help customers and partners fundamentally change the cost and quality of healthcare in Canada.
What sets McKesson Canada apart
Montreal’s Top Employers evaluated McKesson Canada in a number of categories, including community involvement, physical workplace and work atmosphere, as well as work environment and culture.
At McKesson Canada, employees can take advantage of charitable donation matching and volunteering grants available to eligible charities, and everyone is encouraged to join our employee resource groups (ERGs). These peer-led, company-sponsored groups promote, develop, and advance employees connected by shared cultures, backgrounds, and interests, and are dedicated to advancing diversity and inclusion within the organization.
After a recent and extensive renovation, McKesson Canada’s Montreal office now has more areas for social interaction (such as a game room, fitness centre and Centraide store), more meeting rooms and collaboration space, and more technology, allowing for even greater connectivity and productivity in the workplace.
Through its several programs and employee initiatives, McKesson Canada has cultivated a culture of caring, meaning and belonging, with the goal of being the best place to work in healthcare. To learn more about why McKesson Canada was selected as one of Montreal’s Top Employers, read the complete employer review. For more information on career opportunities with McKesson Canada, visit mckesson.ca/en/careers.
About Montreal’s Top Employer Awards
First published in 2006, Montreal's Top Employers is an annual competition organized by the editors of Canada's Top 100 Employers. This special designation recognizes the employers in Greater Montreal that lead their industries in offering exceptional places to work. Employers are evaluated by the editors of Canada's Top 100 Employers using the same eight criteria as the national competition: (1) Physical Workplace; (2) Work Atmosphere & Social; (3) Health, Financial & Family Benefits; (4) Vacation & Time Off; (5) Employee Communications; (6) Performance Management; (7) Training & Skills Development; and (8) Community Involvement. Employers are compared to other organizations in their field to determine which offer the most progressive and forward-thinking programs. Any employer with its head office or principal place of business in Greater Montreal may apply for this competition. Employers of any size may apply, whether private or public sector.
About McKesson Canada
McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver products, services and insights to help make quality care more accessible and affordable.
Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.
For more information:
Sybil Millar
Senior Advisor, Media Relations and External Communications
media@mckesson.ca
11/01/24
Roche Canada and McKesson Canada Inaugural Innovation Challenge Enhances the Patient Experience
MISSISSAUGA, ON - January 11, 2024 - Hoffmann-La Roche Limited (Roche Canada) is proud to announce a dynamic collaboration with McKesson Canada (McKesson) which has resulted in solutions that will optimize the patient journey and potentially shorten overall time to therapy.
The two industry leaders brought collaborative teams together for an intensive six-week innovation challenge aimed at removing barriers, enhancing the patient experience, streamlining administrative processes, and expediting reimbursement within existing patient support programs. This collaboration demanded a creative approach to strategically design solutions within the constraints of available resources.
When a patient is diagnosed with a chronic condition or disease like Multiple Sclerosis (MS) or cancer, it can be challenging to navigate the complex healthcare systems. Patient Support Programs (PSPs) work to simplify the process and ease the patient’s experience.
“Roche created this innovation challenge to explore what could be possible in the patient support program space and to see what - with an open-minded partner like McKesson Canada - we could do differently, better, faster for patients,” said Roger Tam, Vice President, Legal, Compliance, and Innovation at Roche Canada. “Design thinking empowered Roche Canada and McKesson Canada employees to frame opportunities and create solutions that will deliver significant value to all stakeholders, especially patients.”
The innovation challenge culminated in a pitch competition, where teams presented their proposals to a seasoned panel of leaders from both Roche Canada and McKesson Canada. The pitches underwent rigorous evaluation, resulting in the prioritization of the highest-scoring proposal for implementation over the next six to 12 months. Ultimately, the panel found all solutions to be compelling enough for implementation; it was simply a matter of determining the optimal timeline for each.
The two winning innovations addressed the cumbersome administrative challenges experienced by both patients and healthcare providers during PSP enrolment. Through streamlined processes, these solutions not only minimize time and redundancy for all stakeholders but also significantly accelerate access to vital therapies.
“When you have a patient with a complex disease, you do everything you can to get them to critical treatment as fast as you can,” said Rebecca Yu, Vice President/General Manager, Biopharma Operations & Customer Experience, McKesson Canada. “The Roche McKesson Innovation Challenge shows what is possible when you change your approach, share a common goal and come together with committed partners. We are tremendously proud of our teams and inspired by the value they have created with new solutions that will positively impact care and experience for patients!”
McKesson Canada is a Patient Support Program partner to Roche Canada and works to simplify a patient’s health journey by helping them to navigate the various healthcare systems, including supporting the administration process to ensure timely access to treatment.
The success of this innovation challenge not only underscores Roche Canada and McKesson Canada’s ability to swiftly implement ideas but also marks a pivotal step towards fostering a proactive culture of idea sharing, collaboration and innovation. Roche Canada and McKesson remain committed to revolutionizing PSPs and setting a new standard for excellence in patient care and experience.
About Roche Canada
Patients and science are at the heart of everything we do. At Roche, our passion for science and our commitment to relentlessly pursuing the impossible for patients has made us one of the world’s leading pharmaceutical, in vitro diagnostics, and healthcare technology companies. And we’re adding our expertise in new areas, such as artificial intelligence, real world data collection and analysis and collaborating with many different sectors and industries.
We're an innovator across major disease areas, including oncology, infectious diseases, diabetes, ophthalmology, and diseases of the central nervous system.
Roche Canada was founded in 1931 and employs more than 1,800 people across the country through its Pharmaceuticals division in Mississauga, Ontario as well as its Diagnostics and Diabetes Care divisions in Laval, Quebec. For more information, please visit www.RocheCanada.com, or follow Roche Canada on LinkedIn, or on Twitter @RocheCanada.
About McKesson Canada
McKesson Canada is a diversified health-care services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of health care at www.McKesson.ca.
For information, contact:
Jennifer Mota
Roche Canada
Jennifer.mota@roche.com
Michelle Lee-Gracey
McKesson Canada
media@mckesson.ca
A significant public policy priority for the Government of Canada is ensuring comprehensive, timely, and equitable access to medication for rare diseases; as such, the Government of Canada has allocated $500 million annually to a national strategy for rare disease drugs. McKesson Canada is proud to contribute to this conversation, drawing on experience with patient support programs, pharmaceutical distribution, and specialty pharmacy services.
The Government of Canada would like to develop a solution to ensure universal drug coverage for Canadians. This solution would mean all Canadians would have access to a comprehensive, affordable drug insurance plan regardless of their province of residence or financial situation. Where the coverage comes from is an important consideration, but what ultimately matters is that all Canadians can acquire the medicine they need regardless of their particular financial, geographic or health circumstances.
